Positive mid-stage results with Apogee Therapeutics' IL-13 inhibitor APG777 in atopic dermatitis have driven the company's shares up around 20%, as it prepares for a phase 3 programme. The 16-week ...
At close: February 13 at 4:00:02 PM EST ...
Find out the direct holders, institutional holders and mutual fund holders for Apogee Enterprises, Inc. (APOG).
Chart does not reflect overnight price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results